Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis
The American Journal of MedicinePublished 1 December 2004
Brahmajee K. Nallamothu, Kaveh G Shojania, Sanjay Saint, Timothy P. Hofer, H. David Humes, Mauro Moscucci
Citations188
SJR quartileQ1
SJR score1.00
SNIP1.04
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
High-quality, large clinical trials are needed before acetylcysteine use in this indication can be recommended universally, and this finding is reported inconsistently across currently available trials.
Abstract
Acetylcysteine may reduce the incidence of contrast-related nephropathy, but this finding is reported inconsistently across currently available trials. High-quality, large clinical trials are needed before acetylcysteine use in this indication can be recommended universally.
Keywords
Medicine
BMJBias in meta-analysis detected by a simple, graphical test
56,268 Citations1997Matthias Egger, George Davey Smith +2 more
Funnel plots, plots of the trials' effect estimates against sample size, are skewed and asymmetrical in the presence of publication bias and other biases Funnel plot asymmetry, measured by regression analysis, predicts discordance of results when meta-analyses are compared with single large trials.
JAMAEmpirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
5,580 Citations1995Klaus‐Peter Schulz
Empirical evidence is provided that inadequate methodological approaches in controlled trials, particularly those representing poor allocation concealment, are associated with bias.
The LancetImproving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
4,808 Citations1999David Moher, Fadi Hammal +4 more
This report hopes this report will generate further thought about ways to improve the quality of reports of meta-analyses of RCTs and that interested readers, reviewers, researchers, and editors will use the QUOROM statement and generate ideas for its improvement.
JAMAThe Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
1,983 Citations1999Peter Jüni
The data indicate that the use of summary scores to identify trials of high quality is problematic, and relevant methodological aspects should be assessed individually and their influence on effect sizes explored.
The LancetISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction
1,817 Citations1995
58,050 patients entering hospitals up to 24 h after the onset of suspected acute myocardial infarction with no clear contraindications to the study treatments were randomised in a "2 x 2 x 2 factorial" study, reassuring a bout the safety of using nitrates early in acute MI.
The American Journal of MedicineAcute Renal Failure After Coronary Intervention
1,675 Citations1997Peter A. McCullough, Robert Wolyn +3 more
The occurrence of ARFD after coronary intervention is rare (<1%) but is associated with high in-hospital mortality and poor long-term survival and individual patient risk can be estimated from calculated CrCl, diabetic status, and expected contrast dose prior to a proposed coronary intervention.
New England Journal of MedicinePrevention of Radiographic-Contrast-Agent–Induced Reductions in Renal Function by Acetylcysteine
1,586 Citations2000Martin Tepel, Markus van der Giet +4 more
Prophylactic oral administration of the antioxidant acetylcysteine, along with hydration, prevents the reduction in renal function induced by contrast agents in patients with chronic renal insufficiency.
PubMedThe effect of acute renal failure on mortality. A cohort analysis.
1,391 Citations1996Elliott Levy, C M Viscoli +1 more
Renal failure appears to increase the risk of developing severe nonrenal complications that lead to death and should not be regarded as a treatable complication of serious illness.
New England Journal of MedicineEffects of Saline, Mannitol, and Furosemide on Acute Decreases in Renal Function Induced by Radiocontrast Agents
1,250 Citations1994Richard Solomon, Craig Werner +3 more
In patients with chronic renal insufficiency who are undergoing cardiac angiography, hydration with 0.45 percent saline provides better protection against acute decreases in renal function induced by radiocontrast agents than does hydrationWith 0.
New England Journal of MedicineDiscrepancies between Meta-Analyses and Subsequent Large Randomized, Controlled Trials
1,184 Citations1997Jacques LeLorier, Geneviève Grégoire +3 more
The outcomes of the 12 large randomized, controlled trials that were studied were not predicted accurately 35 percent of the time by the meta-analyses published previously on the same topics.
New England Journal of MedicineNephrotoxic Effects in High-Risk Patients Undergoing Angiography
1,128 Citations2003P. Aspelin, P Aubry +4 more
Nephropathy induced by contrast medium may be less likely to develop in high-risk patients when iodixanol is used rather than a low-osmolar, nonionic contrast medium.
New England Journal of MedicineContrast Material-Induced Renal Failure in Patients with Diabetes Mellitus, Renal Insufficiency, or Both
1,014 Citations1989Patrick S. Parfrey, Sheila M. Griffiths +6 more
It is concluded that there is little risk of clinically important nephrotoxicity attributable to contrast material for patients with diabetes and normal renal function or for nondiabetic patients with preexisting renal insufficiency.
Meta‐Analysis Of Controlled Clinical Trials
815 Citations2002Anne Whitehead
This paper presents a meta--analysis procedure for estimating the treatment difference in an individual trial by combining estimates of a treatment difference across trials using individual patient data.
The LancetDoes the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses?
808 Citations2000Laura McAuley, Ba’ Pham +2 more
Whether exclusion of grey literature, compared with its inclusion in meta-analysis, provides different estimates of the effectiveness of interventions assessed in randomised trials is examined.
RadiologyMetaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media.
727 Citations1993Brendan J. Barrett, Euan Carlisle
Use of LOCM may be beneficial in patients with existing renal failure, and the pooled odds of a rise in SCr level of more than 44 mumol/L with LOCM was three times that after HOCM.
International Journal of Technology Assessment in Health CareSome Statistical Methods for Combining Experimental Results
573 Citations1990Nan M. Laird, Frederick Mosteller
The steps an assessor might take in combining data from different studies are delineated and references are provided to provide references for topics not discussed in detail.
BMJMisleading meta-analysis
506 Citations1995Matthias Egger, George Davey Smith
A meta-analysis of treatments in myocardial infarction published in 1992 retrospectively showed that streptokinase was associated with a highly significant fall in mortality by 1977, but it was not widely recommended until 10 years later—after the effect was confirmed in two mega trials.
The LancetAcetylcysteine for prevention of contrast nephropathy: meta-analysis
478 Citations2003Rainer Birck, Stefan Krzossok +4 more
Comparison with periprocedural hydration alone, acetylcysteine with hydration significantly reduces the risk of contrast nephropathy in patients with chronic renal insufficiency andMeta-regression revealed no significant relation between the relative risk of Contrast nephropea and the volume of radiocontrast media administered or the degree of chronic renalInsufficiency before the procedure.
JAMAAcetylcysteine for Prevention of Acute Deterioration of Renal Function Following Elective Coronary Angiography and Intervention
432 Citations2003Jay Kay, Wing Hing Chow +7 more
Acetylcysteine protects patients with moderate chronic renal insufficiency from contrast-induced deterioration in renal function after coronary angiographic procedures, with minimal adverse effects and at a low cost.
Journal of the American College of CardiologyAcetylcysteine and contrast agent-associated nephrotoxicity
364 Citations2002Carlo Briguori, Fiore Manganelli +9 more
In patients with reduced renal function undergoing angiography and/or angioplasty, the amount of contrast agent, but not the administration of prophylactic acetylcysteine, was a predictor of renal function deterioration.
The American Journal of CardiologyAcetylcysteine to prevent angiography-related renal tissue injury (the APART trial)
349 Citations2002Larry J. Díaz‐Sandoval, Bernard D. Kosowsky +1 more
NAC reduces the risk of postcardiac catheterization nephropathy in patients with chronic renal insufficiency and decreased ejection fraction and should be considered as routine prophylaxis in patientswith chronic renal Insufficiency undergoing cardiacCatheterization.
American Journal of Kidney DiseasesPrevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials
344 Citations2004Alvaro Alonso, Joseph Lau +3 more
A meta-analysis of group data extracted from previously published studies to assess the effect of NAC on the prevention of Radiocontrast nephropathy in patients with pre-existing chronic kidney disease found that N-acetylcysteine reduces the risk for RCN in Patients with CKD.
Journal of the American College of CardiologyA rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study
340 Citations2003Christopher Baker, Andrew Wragg +4 more
Oral acetylcysteine should be considered in all patients at risk of RCIN before contrast exposure when time constraints preclude adequate oral prophylaxis, provided the patient is able to tolerate this degree of volume loading.
The American Journal of CardiologyNephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose
335 Citations2002Rosario V. Freeman, Michael A. O’Donnell +11 more
In conclusion, NRD following PCI is a rare complication with a poor prognosis and optimization of procedural variables such as timing of the intervention relative to the diagnostic catheterization, staging coronary procedures, or dosing within the MRCD may help reduce the risk of this complication in high-risk patients.
The American Journal of MedicineThe efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: a meta-analysis
328 Citations1998Sanjay Saint, Joann G. Elmore +3 more
Journal of the American Society of NephrologyContrast Nephropathy
323 Citations2000SEAN W. MURPHY, BRENDAD J. BARRETT +1 more
The purpose of this article is to review recent developments in the area of contrast-induced nephropathy, with particular emphasis on means of minimizing the risk or preventing this important problem.
Kidney InternationalA randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography
300 Citations2002John D. Durham, Christopher Caputo +8 more
N-acetylcysteine was not effective for the prevention of CN after cardiac angiography, and the independent predictors of CN risk were diabetes mellitus and preexisting chronic renal insufficiency.
Journal of the American College of CardiologyAcetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure
290 Citations2002Kou-G.i Shyu, Jun-Jack Cheng +1 more
Prophylactic oral administration of the antioxidant acetylcysteine, along with hydration, reduces the acute renal damage induced by a contrast agent in patients with chronic renal insufficiency undergoing a coronary procedure.
Kidney InternationalSystematic review of the impact of N-acetylcysteine on contrast nephropathy
284 Citations2004Neesh Pannu, Braden Manns +2 more
NAC may reduce the incidence of acutely increased serum creatinine after administration of intravenous contrast, but this finding was of borderline statistical significance, and there was significant heterogeneity between trials.
Catheterization and Cardiovascular InterventionsProspective randomized study of N‐acetylcysteine, fenoldopam, and saline for prevention of radiocontrast‐induced nephropathy
261 Citations2002Suhail Allaqaband, Ramagopal Tumuluri +5 more
In patients with chronic renal insufficiency, NAC or fenoldopam offered no additional benefit over hydration with saline in preventing RCIN, and the efficacy of N‐acetylcysteine, fen oldopam, and saline in preventative preventing radiocontrast‐induced nephropathy was compared.
Journal of the American Society of NephrologyN-Acetylcysteine for the Prevention of Radiocontrast Induced Nephropathy
236 Citations2004Abhijit V. Kshirsagar, Charles Poole +8 more
Research on N-acetylcysteine and the incidence of radiocontrast nephropathy is too inconsistent at present to warrant a conclusion on efficacy or a recommendation for its routine use.
The LancetEarly administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial
212 Citations2002Elliott M. Antman
Early administration of magnesium in high-risk patients with STEMI has no effect on 30-day mortality, and in current coronary care practice there is no indication for the routine administration of intravenous magnesium in patients withSTEMI.
BMC Medical Research MethodologyMore insight into the fate of biomedical meeting abstracts: a systematic review
197 Citations2003Erik von Elm, Michael C. Costanza +2 more
Estimating the proportion of abstracts submitted to meetings that are eventually published as full reports and identifying abstract and meeting characteristics associated with acceptance and publication, using logistic regression analysis, survival-type analysis, and meta-analysis.
European Heart JournalOral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography A randomized controlled trial and review of the current literature
160 Citations2004Ilan Goldenberg
The findings do not support routine prophylactic administration of oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy in chronic renal insufficiency patients undergoing coronary angiography.
American Journal of Physiology-Renal PhysiologyDirect toxic effect of the radiocontrast agent diatrizoate on renal proximal tubule cells
127 Citations1987H. David Humes, Deborah A. Hunt +1 more
It is demonstrated that the radiocontrast agent, diatrizoate, is directly toxic to renal proximal tubule cells and additive to hypoxic cell injury.
The American Journal of CardiologyMeta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy**The opinions, interpretations, conclusions, and recommendations expressed in this article are those of the authors and are not necessarily endorsed by the U.S. Army.
126 Citations2003Daniel W. Isenbarger, Steven M. Kent +1 more
A meta-analysis of the randomized clinical trials of oral N-acetylcysteine for prevention of contrast nephropathy performed to clarify the degree of benefit.
Kidney InternationalThe effect of N-acetylcysteine on renal function, nitric oxide, and oxidative stress after angiography
108 Citations2003Shai Efrati, Victor Dishy +7 more
NAC treatment has renoprotective effect in patients with mild chronic renal failure undergoing coronary angiography that may be mediated in part by an increase in nitric oxide production.
American Heart JournalAcetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography
105 Citations2003J. Bradley Oldemeyer, William Biddle +4 more
In patients with reduced renal function undergoing elective coronary angiography, N-acetylcysteine does not reduce the risk of CIN and is not effective in preventing CIN.
American Journal of Kidney DiseasesEffect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency: a randomized trial
92 Citations2004Jeffrey W.H. Fung, Cheuk‐Chun Szeto +10 more
Oral NAC had no effect on the prevention of CN in patents with moderate to severe renal insufficiency undergoing coronary angiography or interventions, highlighting the need for a large-scale, randomized, controlled trial to determine the exact beneficial effect of NAC.
Catheterization and Cardiovascular InterventionsProphylaxis of contrast‐induced nephropathy in patients undergoing coronary angiography
83 Citations2003Briain D. MacNeill, S. Harding +5 more
In patients with mild to moderate renal impairment undergoing cardiac catheterization, prophylactic treatment with oral acetylcysteine reduces the incidence of contrast‐induced nephropathy.
DrugsRole of Magnesium in Reducing Mortality in Acute Myocardial Infarction
63 Citations1993Koon Teo, Salim Yusuf
It is suggested that magnesium given to patients during AMI can produce significant reductions in mortality and serious morbidity.
Acta CardiologicaAcetylcysteine, coronary procedure and prevention of contrast-induced worsening of renal function
47 Citations2003Joëlle Kefer, Claude Hanet +3 more
The data do not support the systematic use of acetylcysteine before a coronary procedure in patients with normal renal function or mild to moderate chronic renal failure, to prevent contrast-induced nephropathy.
BMJHealthy eating in Wales
42 Citations1995Chris Tudor‐Smith, P. John Clarkson
Health Promotion Wales supports efforts to produce unambiguous and scientifically based advice on fruit and vegetable consumption for the public and agrees that accurate information on current intakes is needed but Carol Williams is incorrect in stating that there were no national numerical goals.
PubMedPrevention of radiocontrast-induced nephropathy with N-acetylcysteine in patients undergoing coronary angiography.
38 Citations2003George Tadros, Elie Mouhayar +4 more
Prophylactic use of acetylcysteine prevented reduction of renal function after coronary angiography, and the benefit was greater in patients with baseline serum creatinine > 2 mg/dl.
PubMedAcetylcysteine for the prevention of radiocontrast -induced nephropathy.
21 Citations2003Martin Tepel
Several prospective, randomized, placebo-controlled studies in patients with moderate renal insufficiency showed that the prophylactic oral administration of acetylcysteine at a dose of 600 mg twice daily along with hydration prevents the reduction in renal function after radiocontrast administration.
PubMed[Absence of nephro-protective effect of acetylcysteine in patients with chronic renal failure investigated by coronary angiography].
15 Citations2003Rafeian Mahmoud, Claude Le Feuvre +5 more
In conclusion, acute renal failure caused by contrast medium is rare in sufficiently hydrated patients with moderate chronic renal failure when a low dose of contrastmedium is used.